Revitalizing psychiatric drug discovery

A review published in June this year in Nature Reviews in Drug Discovery, describes the difficulties in getting successful clinical trials with psychiatric drugs. It states that the main concern is the gap between the molecular/cellular mechanism of a given target and its effects in the neuronal circuits and behavioral/cognitive processes.

Continue reading